EyePoint Pharmaceuticals (EYPT)
(Real Time Quote from BATS)
$11.12 USD
-0.04 (-0.36%)
Updated May 28, 2024 03:57 PM ET
After-Market: $11.12 0.00 (0.00%) 4:14 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | -0.51 |
EPS Last Quarter | -0.55 |
Last EPS Surprise | -61.76% |
ABR | 1.00 |
Earnings ESP
|
-8.50% |
---|---|
Current Year | -2.15 |
Next Year | -2.86 |
EPS (TTM) | -1.82 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.19M | 11.19M | 45.26M | 14.33M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 16.23M | 16.23M | 55.00M | 23.80M |
Low Estimate | 9.25M | 6.25M | 32.43M | 3.00M |
Year ago Sales | 9.11M | 15.20M | 46.02M | 45.26M |
Year over Year Growth Est. | 33.84% | -26.36% | -1.65% | -68.35% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.51 | -0.51 | -2.15 | -2.86 |
# of Estimates | 4 | 3 | 6 | 5 |
Most Recent Consensus | -0.48 | -0.48 | -1.99 | -2.42 |
High Estimate | -0.38 | -0.47 | -1.86 | -2.32 |
Low Estimate | -0.65 | -0.59 | -2.70 | -3.24 |
Year ago EPS | -0.61 | -0.33 | -1.82 | -2.15 |
Year over Year Growth Est. | 16.39% | -54.55% | -18.13% | -33.26% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 5 | 2 |
Down Last 60 Days | 2 | 2 | 5 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.51 | -0.51 | -2.15 | -2.86 |
7 Days Ago | -0.51 | -0.51 | -2.15 | -2.86 |
30 Days Ago | -0.40 | -0.46 | -1.73 | -2.59 |
60 Days Ago | -0.40 | -0.46 | -1.73 | -2.59 |
90 Days Ago | -0.37 | -0.38 | -1.91 | -2.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.54 | -2.19 | -2.80 |
Zacks Consensus Estimate | -0.51 | -0.51 | -2.15 | -2.86 |
Earnings ESP | -8.50% | -4.22% | -2.28% | 2.27% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.55 | -0.33 | -0.33 | -0.61 | NA |
Estimate | -0.34 | -0.60 | -0.62 | 0.41 | NA |
Difference | -0.21 | 0.27 | 0.29 | -1.02 | -0.17 |
Surprise | -61.76% | 45.00% | 46.77% | -248.78% | -54.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more